INR 19.0
(0.42%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 3.79 Million INR | -87.55% |
2022 | 30.5 Million INR | 384.95% |
2021 | 6.28 Million INR | 6.93% |
2020 | 5.88 Million INR | -33.16% |
2019 | 8.8 Million INR | -10.31% |
2018 | 9.81 Million INR | -47.47% |
2017 | 18.68 Million INR | 61.77% |
2016 | 11.54 Million INR | -65.63% |
2015 | 33.6 Million INR | 1.23% |
2014 | 33.19 Million INR | -59.26% |
2013 | 81.46 Million INR | 52.48% |
2012 | 53.43 Million INR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2023 Q2 | 9.77 Million INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 FY | 3.79 Million INR | -87.55% |
2023 Q3 | - INR | -100.0% |
2023 Q4 | 3.79 Million INR | 0.0% |
2022 FY | 30.5 Million INR | 384.95% |
2022 Q4 | 30.5 Million INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 Q2 | 20.59 Million INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2021 FY | 6.28 Million INR | 6.93% |
2021 Q1 | - INR | -100.0% |
2021 Q4 | 6.28 Million INR | 0.0% |
2021 Q2 | 9.22 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2020 Q1 | 6.21 Million INR | -29.4% |
2020 Q4 | 5.88 Million INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2020 FY | 5.88 Million INR | -33.16% |
2020 Q2 | 4.98 Million INR | -19.83% |
2019 Q2 | 3.08 Million INR | 0.0% |
2019 FY | 8.8 Million INR | -10.31% |
2019 Q4 | 8.8 Million INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2018 Q1 | 9.23 Million INR | -50.59% |
2018 FY | 9.81 Million INR | -47.47% |
2018 Q4 | 9.81 Million INR | 0.0% |
2018 Q3 | 9.81 Million INR | 6.31% |
2018 Q2 | 9.23 Million INR | 0.0% |
2017 FY | 18.68 Million INR | 61.77% |
2017 Q1 | - INR | 0.0% |
2017 Q2 | 15.18 Million INR | 0.0% |
2017 Q4 | 18.68 Million INR | 0.0% |
2017 Q3 | 18.68 Million INR | 23.06% |
2016 FY | 11.54 Million INR | -65.63% |
2015 FY | 33.6 Million INR | 1.23% |
2014 FY | 33.19 Million INR | -59.26% |
2013 FY | 81.46 Million INR | 52.48% |
2012 FY | 53.43 Million INR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Sigachi Industries Limited | 707.2 Million INR | 99.463% |
Ind-Swift Limited | 640.91 Million INR | 99.408% |
Bajaj HealthCare Limited | 1.44 Billion INR | 99.736% |
Sakar Healthcare Limited | 277.32 Million INR | 98.631% |
Aurobindo Pharma Limited | 98.08 Billion INR | 99.996% |
Innova Captab Limited | 1.44 Billion INR | 99.736% |
Divi's Laboratories Limited | 31.84 Billion INR | 99.988% |
AstraZeneca Pharma India Limited | 2.27 Billion INR | 99.833% |
Morepen Laboratories Limited | 2.48 Billion INR | 99.847% |
Mankind Pharma Limited | 15.53 Billion INR | 99.976% |
Sequent Scientific Limited | 3.46 Billion INR | 99.89% |
Wanbury Limited | 360.23 Million INR | 98.946% |
Laurus Labs Limited | 18.45 Billion INR | 99.979% |
Nectar Lifesciences Limited | 7.09 Billion INR | 99.946% |
Glenmark Life Sciences Limited | 6.66 Billion INR | 99.943% |
Alembic Limited | 113.4 Million INR | 96.652% |
Hikal Limited | 3.03 Billion INR | 99.875% |
Alembic Pharmaceuticals Limited | 16.43 Billion INR | 99.977% |
Neuland Laboratories Limited | 3.5 Billion INR | 99.892% |
J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 99.924% |
Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 99.985% |
IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 99.911% |
Themis Medicare Limited | 705.74 Million INR | 99.462% |
RPG Life Sciences Limited | 1.01 Billion INR | 99.624% |
Zydus Lifesciences Limited | 34.41 Billion INR | 99.989% |
Lupin Limited | 49.53 Billion INR | 99.992% |
Amrutanjan Health Care Limited | 289.04 Million INR | 98.686% |
Wockhardt Limited | 6.4 Billion INR | 99.941% |
Aarti Pharmalabs Limited | 6.42 Billion INR | 99.941% |
Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | 97.468% |
Jubilant Pharmova Limited | 12.89 Billion INR | 99.971% |
FDC Limited | 3.88 Billion INR | 99.902% |
Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 99.994% |
Kilitch Drugs (India) Limited | 39.88 Million INR | 90.479% |
Eris Lifesciences Limited | 1.89 Billion INR | 99.799% |
Venus Remedies Limited | 1.21 Billion INR | 99.688% |
ZIM Laboratories Limited | 812.62 Million INR | 99.533% |
Bliss GVS Pharma Limited | 1.18 Billion INR | 99.679% |
Par Drugs and Chemicals Limited | 41.77 Million INR | 90.91% |
Caplin Point Laboratories Limited | 3.63 Billion INR | 99.895% |
Shilpa Medicare Limited | 3.44 Billion INR | 99.89% |
Albert David Limited | 436.12 Million INR | 99.129% |
Ajanta Pharma Limited | 8.28 Billion INR | 99.954% |
Hester Biosciences Limited | 755.81 Million INR | 99.498% |
Suven Pharmaceuticals Limited | 2.31 Billion INR | 99.836% |
Solara Active Pharma Sciences Limited | 3.59 Billion INR | 99.894% |
Gufic Biosciences Limited | 2 Billion INR | 99.811% |
Windlas Biotech Limited | 621.89 Million INR | 99.389% |
Procter & Gamble Health Limited | 1.09 Billion INR | 99.652% |
Aarey Drugs & Pharmaceuticals Limited | 346.75 Million INR | 98.905% |
Mangalam Drugs & Organics Limited | 1.23 Billion INR | 99.693% |
Granules India Limited | 13 Billion INR | 99.971% |
Aarti Drugs Limited | 4.85 Billion INR | 99.922% |
Bal Pharma Limited | 878.11 Million INR | 99.568% |
Alkem Laboratories Limited | 26.61 Billion INR | 99.986% |
Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.996% |
Lincoln Pharmaceuticals Limited | 771.68 Million INR | 99.508% |
Medicamen Biotech Limited | 593.75 Million INR | 99.361% |
Unichem Laboratories Limited | 7.04 Billion INR | 99.946% |
Bafna Pharmaceuticals Limited | 296.41 Million INR | 98.719% |
Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | 85.108% |
Valiant Laboratories Limited | 100.15 Million INR | 96.209% |
Orchid Pharma Limited | 2.64 Billion INR | 99.856% |
Medico Remedies Limited | 163.37 Million INR | 97.676% |
Ind-Swift Laboratories Limited | 104.57 Million INR | 96.369% |
Ipca Laboratories Limited | 24.71 Billion INR | 99.985% |
Brooks Laboratories Limited | 96.1 Million INR | 96.049% |
Syncom Formulations (India) Limited | 210.81 Million INR | 98.199% |
Piramal Enterprises Limited | - INR | -Infinity% |
Torrent Pharmaceuticals Limited | 22.79 Billion INR | 99.983% |
NATCO Pharma Limited | 7 Billion INR | 99.946% |
Suven Life Sciences Limited | 7.08 Million INR | 46.408% |
Krebs Biochemicals & Industries Limited | 97.96 Million INR | 96.124% |
Strides Pharma Science Limited | 11.26 Billion INR | 99.966% |
Indoco Remedies Limited | 3.53 Billion INR | 99.892% |
Alpa Laboratories Limited | 136.65 Million INR | 97.221% |
Lasa Supergenerics Limited | 190.43 Million INR | 98.006% |
Sun Pharma Advanced Research Company Limited | 14.79 Million INR | 74.331% |